113 related articles for article (PubMed ID: 22711668)
1. Predicting the future: risk stratification for sudden cardiac death in patients with left ventricular dysfunction.
Passman R; Goldberger JJ
Circulation; 2012 Jun; 125(24):3031-7. PubMed ID: 22711668
[No Abstract] [Full Text] [Related]
2. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
Bunch TJ; Hohnloser SH; Gersh BJ
Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
[No Abstract] [Full Text] [Related]
3. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
Weintraub WS
Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
[No Abstract] [Full Text] [Related]
4. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
Saba S
Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
[TBL] [Abstract][Full Text] [Related]
5. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
Huikuri HV
Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
[No Abstract] [Full Text] [Related]
7. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
[TBL] [Abstract][Full Text] [Related]
8. Sudden death after myocardial infarction--who needs prophylaxis, and when?
Buxton AE
N Engl J Med; 2005 Jun; 352(25):2638-40. PubMed ID: 15972871
[No Abstract] [Full Text] [Related]
9. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
Triedman JK
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
[No Abstract] [Full Text] [Related]
10. [Limitations and possibilities of noninvasive risk stratification for sudden cardiac death].
Tönnis T; Kuck KH
Herz; 2009 Nov; 34(7):506-16. PubMed ID: 20091250
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction.
Exner DV
Curr Opin Cardiol; 2009 Jan; 24(1):61-7. PubMed ID: 19077818
[TBL] [Abstract][Full Text] [Related]
12. Implantable defibrillators and sudden cardiac death.
Josephson M; Wellens HJ
Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
[No Abstract] [Full Text] [Related]
13. Cardiac defibrillators, Kant, and the categorical imperative.
Ribeiro AL; Duarte RH
Am Heart J; 2008 Feb; 155(2):e15; author reply e17. PubMed ID: 18215579
[No Abstract] [Full Text] [Related]
14. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death.
Sweeney MO
Circulation; 2010 Dec; 122(25):2638-41. PubMed ID: 21135359
[No Abstract] [Full Text] [Related]
15. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
[TBL] [Abstract][Full Text] [Related]
16. Primary prevention of sudden cardiac death. do we need to implant a defibrillator in all the patients with low ejection fraction?
Disertori M; El-Sherif N
Ital Heart J; 2004 Sep; 5(9):643-7. PubMed ID: 15568590
[No Abstract] [Full Text] [Related]
17. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.
Suliman FA
N Engl J Med; 1998 Apr; 338(17):1228. PubMed ID: 9556393
[No Abstract] [Full Text] [Related]
18. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.
Fruchter O
N Engl J Med; 1998 Apr; 338(17):1227-8. PubMed ID: 9556392
[No Abstract] [Full Text] [Related]
19. [Arrhythmia risk stratification based on clinical and functional data].
Rostagno C; Lazzeri C; Gensini GF
Ital Heart J Suppl; 2001 Dec; 2(12):1270-7. PubMed ID: 11838347
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
Franqui-Rivera H; Sotomonte JC
P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
